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Experimental methods are commonly used for patient-specific IMRT delivery
verification. There are a variety of IMRT QA techniques which have been proposed
and clinically used with a common understanding that not one single method can
detect all possible errors. The aim of this work was to compare the efficiency and
effectiveness of independent dose calculation followed by machine log file analysis
to conventional measurement-based methods in detecting errors in IMRT delivery.
Sixteen IMRT treatment plans (5 head-and-neck, 3 rectum, 3 breast, and 5 prostate
plans) created with a commercial treatment planning system (TPS) were recalculated
on a QA phantom. All treatment plans underwent ion chamber (IC) and 2D diode
array measurements. The same set of plans was also recomputed with another commercial treatment planning system and the two sets of calculations were compared.
The deviations between dosimetric measurements and independent dose calculation
were evaluated. The comparisons included evaluations of DVHs and point doses
calculated by the two TPS systems. Machine log files were captured during pretreatment composite point dose measurements and analyzed to verify data transfer
and performance of the delivery machine. Average deviation between IC measurements and point dose calculations with the two TPSs for head-and-neck plans were
1.2 ± 1.3% and 1.4 ± 1.6%, respectively. For 2D diode array measurements, the
mean gamma value with 3% dose difference and 3 mm distance-to-agreement was
within 1.5% for 13 of 16 plans. The mean 3D dose differences calculated from two
TPSs were within 3% for head-and-neck cases and within 2% for other plans. The
machine log file analysis showed that the gantry angle, jaw position, collimator
angle, and MUs were consistent as planned, and maximal MLC position error was
less than 0.5 mm. The independent dose calculation followed by the machine log
analysis takes an average 47 ± 6 minutes, while the experimental approach (using
IC and 2D diode array measurements) takes an average about 2 hours in our clinic.
Independent dose calculation followed by machine log file analysis can be a reliable
tool to verify IMRT treatments. Additionally, independent dose calculations have
the potential to identify several problems (heterogeneity calculations, data corruptions, system failures) with the primary TPS, which generally are not identifiable
with a measurement-based approach. Additionally, machine log file analysis can
identify many problems (gantry, collimator, jaw setting) which also may not be
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detected with a measurement-based approach. Machine log file analysis could also
detect performance problems for individual MLC leaves which could be masked
in the analysis of a measured fluence.
PACS numbers: 87.53.Bn, 87.55.Qr, 87.55.km, 87.57.Uq
Key words: quality assurance, IMRT, dose calculations, machine log file.
I.

Introduction

Since the introduction of intensity-modulated radiotherapy (IMRT), the physical measurements
and patient-specific QA procedures to validate each IMRT plan before treatment have been
considered an integral component of this delivery technique.(1,2) The comprehensive QA is essential for IMRT due to the complex nature of treatment planning and multitude of interfaces
between the treatment planning system (TPS) and treatment delivery. Recommendations and
guidelines for the appropriate implementation of IMRT and support of an adequate QA program to safely delivery IMRT treatments were provided in recent publications and reports.(2-4)
Currently, experimental methods are predominantly used for patient-specific IMRT delivery
verifications. Typical measurement-based procedures for pretreatment dosimetric verification
include point dose measurements using ion chambers (IC) for a delivery including all treatment
fields at the planned gantry angle, and 2D dosimetry measurement using radiographic films or
2D diode or ion chamber arrays at a vertical gantry angle for individual IMRT fields.(5-9)
Traditional measurement-based QA verification techniques may not be sensitive enough to
detect many types of failures (such as plan transfer errors, beam delivery error, dose calculations
errors) in the IMRT process.(10,11) Traditional IMRT QA processes rely on dose verification
measurements in water equivalent plastic phantoms, which do not represent patient geometry
or tissue heterogeneities. This oversimplification may not be able to identify calculation errors
in some treatment sites. Additionally, creation of QA plans in the primary TPS requires recalculation of dose on the water equivalent phantom or 2D measurement array. This recalculation
breaks the connection between the patient treatment plan and the QA plan, and any potential
errors which were present in the calculation of the patient treatment plan may not be propagated
to the phantom QA plan due to resetting of the calculation. Furthermore, experimental methods
are time-consuming and labor-intensive, and require access to the treatment machine. There is
a growing interest in using independent dose calculation(12-15) and machine log files(16-18) for
QA of IMRT delivery. Dietmar et al.(13) have proposed a semi-analytical fluence based dose
calculation for patient-specific monitor unit (MU) verification. Monte-Carlo–based independent
dose calculations have been suggested for routine IMRT verification(14) and even to replace the
dosimetric verification in phantom.(15) In addition to research and clinical interest, the commercial interest in independent dose calculation for IMRT is growing and tools have become
commercially available.(19,20) Recently there is still a debate to evaluate the necessity and effectiveness of dosimetric validation of each individual IMRT treatment plan with dosimetric
plan before delivery.(12) The machine log file analysis has been proposed as an alternative for
IMRT QA by several groups.(16) Log files have been used to study step-and-shoot and dynamic
MLC deliveries.(17,18) A commercial software that automatically verifies delivery accuracy
for patient treatment using the machine log files has become available. In our department,
log file analysis has been a routine component of patient-specific IMRT QA procedure for
several years.(21)
It has been shown that no single QA technique can mitigate all the errors that can happen
in the IMRT process.(22,23) Table 1 shows a qualitative analysis of relative effectiveness of
different IMRT verification for catching errors that can happen in IMRT delivery. It is critical to evaluate the efficiency and effectiveness of traditional QA approaches, and explore the
possibility of augmenting or replacing current QA techniques with more effective, systematic,
Journal of Applied Clinical Medical Physics, Vol. 13, No. 5, 2012
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Table 1. A qualitative analysis of effectiveness of QA techniques to catch some potential discrepancy or error that
could happen in an IMRT treatment. Note: only a few are mentioned here and only pretreatment QA techniques
are analyzed.
						
			
Field-by-Field
Composite		
Data Transfer, Delivery Error,
Point Dose
Planar Dose
Planar Dose
DynaLog
Planning Error Type
Measurementa
QAb
QAc
QAd
Beam Parameters Discrepancy
During Data Transfer or
Machine Delivery
Gantry Angle
Collimator Jaw Setting
Collimator Angle
MLC Positioning Error
MUs
Couch Angle Error
Machine Issues/Data
Transfer Issues
Dosimetry Characteristic –
Energy Change, Symmetry and
Flatness Off
Absolute Dose Output Calibration
Relative Dose Output – Small
Field Output Off
One Segment Dropped Out or
Not Transferred Properly
One Field Not Transferred Correctly
Demanding MLC Sequence or
MLC Positioning Issues – Beam
Hold Off

				
3
5
4
1
3
3
3
1
3
3
3
1
4
3
3
1
1
1
3
5
2
5
2
5

Independent
Dose
Calculation
QAe

5
5
5
5
5
5

				
4

4

4

5

5

5

5

5

5

5

1

1

1

5

5

4

3

4

1

5

4

2

3

1

5

4

4

4

1

5

TPS Beam Modeling Issues
Small Field Out Prediction Issue
Heterogeneity Correction Issues
Wrong CT to ED
DVH Calculation Discrepancy

				
2
2
2
5
5
5
5
5
5
5
5
5
5
5
5
5

1
1
2
1

In vivo Changes
Beam Data Modification After
Pretreatment QA and Other Machine
Issues During Each Fraction

				

IGRT Issues
Anatomy Changes, localization
Issues, Setup Issues
Treatment Planning
Isocenter Placement, Prescription,
Wrong CT Voxel Size, Plan Quality

5

5

5

5

5

				
5

5

5

5

5

				
5

5

5

5

5

Note: 1 is most effective, 4 is least effective, and 5 is not possible to find from QA test results.
a	 Point dose measurement refers to ion chamber measurement with one or two points in a composite fashion (i.e., all
beam delivered to a water equivalent phantom as it would be delivered to the patient).
b	 Field-by-field planar dose measurement: all beams delivered from AP direction with gantry and could reset to default
position.
c	 Composite planar dose QA refers to measuring a plane using a 2D detector embedded in a phantom and the QA is
performed with actual beam parameters as it will be delivered to the patients.
d	 DynaLog QA: analysis of machine log file collected by delivering the actual plan to air or during composite point or
planar dose measurement, as explained in a) and c).
e	Independent dose calculation is verifying the dose distribution of the planning system by recalculating in an independent dose calculation by exporting DICOM RT files (Plan, Dose, Images, Structure set ) and any POIs.
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reliable, and efficient methods. In this work, we have evaluated the efficiency and effectiveness
of independent dose calculation in combination with machine log files analysis as an approach
to IMRT QA. We accomplish this by:
a) Comparing the efficiency and accuracy of dose calculation and machine log file analysis
QA paradigm against current measurement based technique.
b) Evaluating the potential of two paradigms for error detection effectiveness and reliability.
To do this, we chose to use another commercial treatment planning system to verify the
IMRT dose distribution computed by the primary treatment planning system. Independent dose
calculation does not verify the MLC performance during IMRT delivery, although it may reduce
or reveal errors/inconsistencies in the treatment planning system and process. We propose to
perform the machine log file analysis to supplement the calculation-based QA to validate data
transfer and delivery performance of MLCs.
II. Materials and Methods
A. Treatment plans
In the present study, 16 IMRT plans have been evaluated by experimental methods and by an
independent dose calculation method followed by machine log file analysis. Treatment plans with
fixed beams and static multileaf collimator (SMLC) IMRT treatment plans were chosen for this
study. Treatment sites and number of plans included in the study were: 5 head-and-neck plans,
3 rectum plans, 3 breast plans all using 6 MV, and 5 prostate plans using 18 MV. The average
number of beams used in this study for head-and-neck, rectum, breast, and prostate were 9, 9,
10, and 7, respectively. Treatment plans were created using Pinnacle 9.0 TPS (Philips Medical
Systems, Fitchburg, WI). The number of segments used per beam varied between 4–12, while
the total number of segments varied between 40 and 78 per treatment plan. All plans were
optimized using direct machine parameter optimization (DMPO).(24)
B. Verification procedures
B.1 Traditional measurement-based IMRT QA
Figure 1 shows the entire verification process presented in this paper (steps grouped inside
the black box). After an IMRT treatment plan was approved for treatment, it was recalculated
using the same beam orientations and MUs, but replacing the patient CT dataset with a water
equivalent phantom (14 × 14 × 15 cm3). The phantom has inserts to accommodate two smallvolume ionization chambers (IC) anywhere within the box at a 0.5 cm resolution.(6) Two IC
point measurements were performed for each approved plan. Additionally, planar dosimetry
QA for each field of each plan was performed using a 2D diode array (MapCHECK, Sun
Nuclear Corporation, Melbourne, FL) mounted using a custom-built water equivalent plastic
phantom. The MapCHECK device consists of 445 N-type diodes that are in 22 by 22 cm2 2D
array with variable spacing of 7 and 14 mm between diodes. Calculated planned fluences were
copied onto the verification phantom in such a way that the high-dose region is located in the
central area where there is high detector density of the MapCHECK device. The verification
measurements were performed using a static gantry that is perpendicular to the measurement
plane. The measured fluence maps of the individual beams were compared to the fluence maps
computed by the TPS. The goal was that IC measurements should verify the absolute dosimetry, while the planar dosimetry measurements validate the relative dose distributions of the
individual beams.
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Fig. 1. Process flow for independent dose calculations with machine log file analysis and measured-based QA in
our clinic.

B.2 Calculation-based verification method
The proposed calculation-based verification method consists of independent dose calculation
and machine log file analysis. The process for independent calculation-based QA is also shown
in the flowchart of Fig. 1. All treatment plans were generated on the Pinnacle treatment planning system. DICOM RT files which include RT dose, RT plan, RT structures, and CT images
were exported to another commissioned and clinically used commercial treatment planning
system (Eclipse V 8.2.0, Varian Medical Systems, Palo Alto CA). The dose distributions were
recalculated using Eclipses’ analytical anisotropic algorithm (AAA).(25) The point doses and
DVHs were exported in DICOM format and analyzed in Eclipse TPS. The planar dose files
from both treatment planning systems were exported into I’MRT MatriXX (IBA dosimetry,
Bartlett, TN) for qualitative and quantitative gamma analysis. The use of independent dose
calculation is an alternative method to evaluate the accuracy of the treatment planning system’s
dose calculations, including heterogeneity corrections.
The Pinnacle plan was calculated using Collapsed Cone Algorithm with dose grid size of
3 mm × 3 mm × 3 mm while, for Eclipse treatment planning system, Anisotropic Analytical
Algorithm was used with a dose grid size of 2.5 mm × 2.5 mm × 3 mm. Both the systems have
implemented convolution superposition algorithms in their own way. The dose-volume histograms (DVH) were computed using Eclipse TPS for both Pinnacle and Eclipse dose grids. The
DVHs and the point doses of two plans were then evaluated for PTV and critical structures.
The machine log files were captured during pretreatment ion chamber QA measurements.
Varian linear accelerators (linac) write the actual machine parameters every 50 ms, and store
them in a file (DynaLog) on the linac control console and MLC workstation. We used log files
from Varian Trilogy and iX machines which record machine parameters every 50 ms, while
the Varian TrueBeam machine, which records machine parameters every 10–20 ms, was not
Journal of Applied Clinical Medical Physics, Vol. 13, No. 5, 2012
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considered for this study. The DynaLog files include beam on/off status, gantry angle, collimator angle, jaw positions, and MLC leaf positions for all control points and delivered beam MU,
etc. These log files are accessible after the delivery of each fraction of the treatment.
After an IMRT treatment plan is approved, it is exported to the R&V system and delivered
on the linac machine for point dose (IC) QA measurements, and the machine log files stored
during the delivery were transferred to and stored in a folder on a network drive. In this study,
we capture the DynaLog files that were recorded during pretreatment point dose measurement.
In a parallel path, the treatment plan was exported as a DICOM file containing the planned
values of the machine parameters to the same network drive folder. Semi-automatic machine
log file analysis is performed using in-house–developed MATLAB (MathWorks Inc., Natick,
MA) software which compares the patient identification information (name, ID number, etc.),
log file integrity, and the delivered machine parameters for each beam with the respective
planned values. Beam parameters include gantry angle, collimator angle, number of segments,
and MLC leaf positions for all control points. In addition, based on the beam on/off status and
MLC leaf positions retrieved from the machine log files, the software computes the equivalent
fluence map (in MUs) at the isocenter for each delivered beam, compares it against the planned
beam fluence map reconstructed using the same algorithm, and calculates pixel-by-pixel fluence
difference between the two maps. Finally, the software generates a summary report of all the
beam parameters, and three fluence maps for each beam. The report is color-coded and includes
warning messages for parameters that are outside specified tolerances.
III. Results
A. Evaluation of measurement based IC and planar dosimetry IMRT QA
In the past three years, we have performed ~ 4000 IMRT QAs with ion chambers, field-by-field
planar dosimetry and composite planar dosimetry. We have not found any errors that would
result in replanning of the patient treatment or modification of treatment delivery parameters.
We have treated variety of different sites with SMLC and DMLC technique. However, we have
repeated ~ 15% of the QA measurements because of incorrectly generated/delivered QA plan,
equipment failures, selected points being in high dose gradient regions, or wrong documentation of QA plan (shifts or point coordinates), resulting in additional time and resources. While
this is true, it doesn’t mean that there were no discrepancies between planned and delivered
treatments. We have found instances where there were discrepancies in the R&V system that
were caused by data entry or other human errors, and for which the pretreatment QA methods
were insensitive and therefore did not catch, but that were discovered during initial and weekly
chart checks.
B.	Validation of independent dose calculation and machine log QA paradigm with
measurements
The IMRT phantom plans were verified with ICs and MapCHECK. For composite IMRT plan
deliveries, average deviation between IC measurements and point dose calculation with Pinnacle and Eclipse for head-and-neck plans for all the selected patients were 1.2 ± 1.3% and
1.4 ± 1.6%, respectively (Table 2). MapCHECK measurement and dose distribution computed
from Pinnacle were compared using the gamma evaluation method with 3% dose difference
and 3 mm distance-to-agreement as acceptance criteria. Dose distributions obtained from Pinnacle were used as reference. Table 2 also lists the average gamma passing rate for the various
treatment sites.
Figure 2 represents typical line dose profiles of the calculations and measurements for a
single head-and-neck (H&N) treatment field. The insert shows the dose distribution and the
position of the line profile. Both the calculated dose distribution using Eclipse and measured
using MapCHECK match quite well with the calculated from Pinnacle. Figure 3 shows the
Journal of Applied Clinical Medical Physics, Vol. 13, No. 5, 2012
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 istograms of the deviations of the MapCHECK measurements and Eclipse calculations comh
pared to Pinnacle calculated IMRT plan on a pixel-by-pixel basis for the H&N patient presented
in Fig. 2. The results demonstrate a little broadening of measurement data and not in the eclipse
Table 2. Ion chamber measures to validate independent dose calculation technique.

Treatment Site
Head-and- Neck
Breast
Prostate
Rectum

Eclipse Calculated Dose /
Pinnacle Calculated Dose
(Avg ± STD)
IC1
IC2
0.972±0.005
0.990±0.004
0.995±0.01
0.975±0.008

0.980±0.009
0.996±0.01
1.01±0.004
1.005±0.01

Measured / Pinnacle
Calculated Dose
(Avg ± STD)
IC1
IC2
1.022±0.008
1.010±0.006
0.994±0.009
1.017±0.016

1.013±0.010
1.009±0.020
0.997±0.012
1.017±0.025

MapCHECK Gamma
Passing Rate
(Avg ± STD) %
96.3±1.62
94.8±1.13
98.2±0.58
94.9±1.68

Fig. 2. Line dose profiles for an H&N IMRT plan verified by MapCHECK for Pinnacle and Eclipse calculations.

Fig. 3. Dose difference derived from the difference between measurements vs. Pinnacle and Eclipse calculations vs.
Pinnacle.
Journal of Applied Clinical Medical Physics, Vol. 13, No. 5, 2012
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calculations. The broadening of the MapCHECK measurements may be from the small errors
in positioning the phantom and the resolution of the diode array.
The dose calculations using two different treatment planning systems were also compared
based on the treatment site. Figure 4 shows the dose map of a representative head-and-neck
case obtained with Pinnacle and Eclipse. Figure 4(c) and (d) shows the difference in dose and
in gamma function analysis. The 2D gamma evaluation quantity was calculated using 3%
dose and 3 mm spatial acceptance criteria. Table 3 shows the DVH indices for head-and-neck
and rectum corresponding to Pinnacle and Eclipse. The mean dose differences are within 2%
for both cases. In the same way, Table 4 lists the DVH indices for breast and prostate cases.
The independent dose calculation deviates from Pinnacle by less than 1.8% for both PTV and
critical structures.
It has been pointed out that independent dose calculations based on the exported DICOM
file from Pinnacle to Eclipse do not check the potential error in the actual MLC performance of
the treatment unit and accuracy of the delivery. The machine log files analysis for two beams
delivered for a head-and-neck patient, shown in Fig. 5, reveals the fluence maps of planned and
delivered (without considering the scattering) and their difference. This report also includes
the status of several beam parameters including gantry angle, collimator angle, jaw positions,
delivered MU, and MLC errors. If the actual parameters are within the set tolerance, the check
results are displayed in green, otherwise as a “warning” in yellow. The tolerances for gantry
angle, collimator, jaw position, and MLC leaf positions are 0.1°, 0.1°, 1 mm and 2 mm, respectively. We have found that the maximal MLC errors for the 16 patients were less than 0.5 mm.
The passing rate at 2% (3%) means the percentage of the number of pixels with error less than
the 2% (3%) of the maximal fluence (in MU) of the entire beam.

Fig. 4. Dose map of a representative H&N case obtained with Pinnacle and Eclipse: (a) from Pinnacle; (b) from Eclipse;
(c) difference; (d) 2D gamma.
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Table 3. DVH indices for head-and-neck and rectum cases.
PTV & Critical 		
Structures
Dose Indices

Head-and-Neck
Pinnacle
Eclipse
(Avg.±SD)
(Avg.±SD)

Pinnacle
(Avg.±SD)

Rectum

Eclipse
(Avg.±SD)

		
		
		
PTV1
		
		
		

V 95%
V 105%
V 107%
Min. dose %
D5%-95%
D3%-93%
Mean dose (cGy)

98.7±1.3
34.3±33.2
14.3±17.7
96.9±2.0
8.9±2.8
8.4±2.5
7236.3±140.3

96.9±1.7
23.4±25.3
8.2±10.0
95.0±1.9
10.0±2.9
9.8±2.7
7143.0±172.3

96.9±5.4
16.7±25.3
5.3±9.0
96.3±4.9
7.4±3.2
7.2±3.1
4281.1±1543.0

95.8±7.3
16.1±26.5
5.7±9.8
95.9±5.1
7.5±3.1
7.4±3.0
4270.7±1550.6

		
		
		
PTV2
		
		
		

V 95%
V 105%
V 107%
Min. dose
D5%-95%
D3%-93%
Mean dose (cGy)

99.6±0.0
69.3±11.6
51.9±12.6
97.0±0.2
20.4±5.0
22.0±5.4
5937.7±109.60

99.1±0.3
58.1±7.3
41.2±6.7
95.3±0.7
20.7±4.8
22.4±4.9
5862.2±128.3

98.8±1.2
72.8±9.4
62.1±8.5
95.8±4.2
21.7±9.0
21.4±9.1
4035.1±1566.2

98.5±1.5
71.0±11.2
60.3±10.1
95.3±4.8
21.6±8.7
21.3±8.7
4025.2±1570.7

Lt. Parotids
		

V26Gy
Mean dose (cGy)

62.0±32.1
3586.6±1801.1

59.9±30.7
3494.6±1736.3

---

---

Rt. Parotids
		

V26Gy
Mean dose (cGy)

53.7±40.4
3122.4±2020.3

52.3±40.7
3068.4±2016.6

---

---

Spinal Cord

Max. dose

3762.1±260.6

3599.2±257.2

--

--

Small Bowel
		

V40Gy
Mean dose (cGy)

---

---

582.0±988.4
1780.2±1102.2

595.7±1012.2
1772.2±1097.8

Table 4. DVH indices for breast and prostate cases.
PTV & Critical
Structures

Breast

Pinnacle
(Avg.±SD)

V 95%
V 105%
V 107%
Min. dose
D5%-95%
D3%-93%
Mean dose

89.9±12.5
3.6±5.1
0.6±0.8
95.4±0.9
8.1±0.1
8.1±0.1
4988.5±148.4

77.9±23.5
1.5±2.1
0.2±0.2
94.0±1.4
8.8±0.3
8.7±0.2
4923.2±147.6

100.0±0.1
32.1±31.4
1.9±2.6
100.7±0.6
3.1±1.4
3.1±1.3
6779.6±34.8

100.0±0.0
47.7±37.9
12.4±17.0
100.8±1.3
3.6±1.7
3.5±1.6
6828.6±50.1

Ipsilateral Lung
		

V20
Mean dose (cGy)

26.3±3.8
1363.4±63.1

26.0±3.9
1375.4±66.5

---

---

Heart
		

V20
Mean dose (cGy)

6.7±9.5
982.7±506.2

6.8±9.7
965.0±524.0

---

---

		
		
		
PTV
		
		
		

Spinal Cord

Eclipse
(Avg.±SD)

Prostate
Pinnacle
Eclipse
(Avg.±SD)
(Avg.±SD)

Dose
Indicies

Max. dose (cGy)

1241.7±354.1

1267.3±323.1

--

--

		
Rectum
		

V65
V40
Mean dose (cGy)

----

----

10.3±1.4
27.1±1.8
2721.6±171.6

10.5±1.3
27.3±2.0
2743.2±152.0

		
Bladder
		

V65
V40
Mean dose (cGy)

----

----

15.6±5.6
25.9±6.8
2408.5±534.0

16.0±5.6
26.6±6.9
2461.7±529.9
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Fig. 5. Machine log analysis. Gantry, jaw, and collimator angle, MLC positions, MU, and fluence map are compared.
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C. 	Efficiency of independent dose calculation and machine log file analysis
paradigm
Table 5 shows the comparison of the total time for experimental IMRT verification in solid
phantom, based on IC and MapCHECK measurements, and calculation-based approach. The
independent dose calculation with the machine log analysis can be done during the day and
only takes 32 minutes. This time comparison favors the independent dose calculation, as the
experimental approach takes about 2 hours.
Table 5. Process flow timeline.
			
Steps
Time Scale
1
		
2
3
4
5
6
7
8
9

Experimental-based
Approach

Making a verification plan for measurements
35 min
(IC and 2D verification plans)
Exporting verification plan for delivery
3 min
1D and 2D verification at LINAC	 60 min
Data analysis of the measurement data
15 min
Export the plan from Pinnacle to Eclipse
Independent dose calculation in Eclipse
- 	
DVH comparison and analysis
Machine log analysis
Documentation
5 min

Total Time 	 	

118 min

Computation-based
Method
15(capturing DynaLog)
10 min
8 min
6 min
3 min
5 min
47 min

IV. DISCUSSION
There are many potential errors that can arise during the IMRT planning and delivery, such as
dose calculation inaccuracies, plan transfer errors, beam delivery errors, patient setup errors,
and target location uncertainties due to organ motion. A comprehensive quality assurance program should be established to efficiently check these potential errors and to ensure that dose
distribution planned on an IMRT treatment planning system will be delivered accurately and
safely. Current patient-specific QA techniques are performed by irradiating a water equivalent
phantom that contains film, IC arrays or equivalent dose measurement tools to verify that the
dose delivered is the dose planned. These methods can detect large errors in beam delivery, but
might not detect dose calculation errors. Furthermore, the verification measurements are based
on the homogenous phantom, which does not take into account the heterogeneities in patient’s
anatomy. The measurement-based QA methodology in water equivalent phantoms may not
catch the errors associated with lack of electronic equilibrium caused by small segments in the
presence of heterogeneities. The independent dose calculation can catch the serious errors in
heterogeneity calculation or beam modeling.
It has been recognized that today’s patient-specific measurement-based QA has serious
limitations and it is also time-consuming and labor-intensive. The value of validating individual
plans has been questioned, and there has been a debate whether validating treatment plan is
worthwhile after the commission process has been completed.(12,26,27,28) With IMRT, proper
commissioning will help avoid most systematic errors. Independent dose calculation can serve as
an alternative verification method which can free up time for the physicist to evaluate the entire
scope of an IMRT treatment. The other advantage of independent dose calculation method is that
the linear accelerator time is not required. And the independent dose calculation and machine
log file analysis can be done, on average, in 32 minutes, which is much more efficient than the
measured-based QA approach. The efficiency of the independent dose computation and log file
analysis method can be improved by designing a fully automatic QA tool. A comprehensive
commercial solution that would automate the whole process will make it even more efficient.
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In this study, we have used the 2D gamma to evaluate the dose distribution accuracy between
planning systems, but a full 3D gamma evaluation would be useful. 3D gamma can also aid
us finding discrepancy in areas that are not contoured as structures where discrepancy cannot
be figured out from DVH metrics. This 3D gamma tool would add additional robustness to the
independent dose calculation-based QA paradigm.
We used a commercial treatment planning system as an independent dose calculator instead
of Monte Carlo method because Eclipse is a FDA-approved commercial treatment planning
system and the dose calculations on this system are reasonably fast. The use of Monte Carlo
has been proposed by several authors,(29-30) but we avoided that for two reasons: i) we believe
the goal of the independent dose calculator is to act as a QA tool looking for major errors instead of determining the accuracy of the commissioned treatment planning system algorithm
and beam model; ii) from an efficiency aspect, the time required to compute independent dose
calculations with Monte Carlo are prohibitively long.
It has been realized that the independent dose calculation alone is not sufficient for a comprehensive QA program because the data transfer from the TPS to the linear accelerators and
the performance of the delivery unit are not checked. Therefore, a periodic QA testing of the
machine delivery accuracy is required. Computer-based machine log file analysis should catch
any errors associated with plan transfers and the delivery problems. The machine log file analysis
should authenticate the delivery quality. Also the machine log file QA is a number-to-number
comparison of data transferred from treatment planning system to data delivered by the linear
accelerator and is more sensitive to detecting discrepancies of the order or 1 mm and 1 degree
compared to measurement-based method. The sensitivity of IC and planar dose measurements
is determined by volume of ion chambers and resolution of MapCHECK or MatriXX. In our
clinics, the machine log file QA have detected data transfer errors, jaw position errors, and MLC
errors which were not caught in IC and planar dose measurements.(21) Most of these errors
were related to the data transfer and human error, and the sensitivity and efficiency of the IC
and planar dose measurements in mitigating errors were revealed.(21) This work also leads us
to believe that current QA methodology has short comings.
The workflow for Pinnacle patients using verification by independent dose calculation method
is to export the clinically approved treatment plans to Eclipse planning system to perform independent dose calculations using the AAA algorithm. If the Eclipse dose-volume indices for
PTVs and OARs match the Pinnacle TPS within 3%, the patient should go for treatment without
QA measurements, and one can perform machine log file analysis on the patient’s first treatment
fraction to validate the delivered treatment beam parameters against the planned. The benefit
of doing machine log file analysis on first fraction is that there is no delay in process because
of QA, and the treatment can resume immediately after the plan is ready. Also, any changes to
the treatment record after pretreatment checks are made could be detected. The downside of
this approach is that, if there are any errors in the beam parameters prepared for delivery, the
error would be found only after delivering a dosimetrically different dose than the plan for the
first fraction. Therefore, this methodology may not be suitable for single fraction treatments
as well as hypofractionated ESRT treatments. For this case, a QA beam could be delivered and
the machine log file analysis could be done before the patient treatment. Even if a pretreatment IC QA is performed, it would be a better practice to perform machine log QA analysis
after first fraction to ensure nothing has changed after QA and initial approval. One could also
evaluate a paradigm doing DynaLog QA, which is performed after every field to reduce the
risk. Also DynaLog QA can be performed on pretreatment and also on the first fraction as an
in vivo measurement. In our clinic, we are performing DynaLog QA for every field, for every
fraction, and for every IMRT patient, to study the effectiveness of that paradigm,(31) which will
be reported in a separate manuscript. The method of choice should be based on effectiveness,
efficiency, and safety of the delivery to the patients.
The paradigm shift from measurement-based patient-specific QA verification to a computation-based methodology may have significant gain on the QA timeline and workflow, particularly
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towards implementation of adaptive radiation therapy. However, the transition should be gradual
so as to provide enough confidence in IMRT verifications. At the start of clinical implementation
of any new IMRT technique, it is strongly recommended to perform measurements of the 3D dose
distribution delivered to a phantom and to compare with planned dose distributions. It should
be kept in mind that the computation-based methods do not exclude the measurement-based
methods for some cases. When the independent dose calculations and machine log files analysis
yield an unacceptable result or when the independent dose calculations do not give satisfactory
results, the experimental-based measurement or other investigation should be systematically
performed to track the errors. Also, at the time of upgrade or when any major component of
treatment planning program is upgraded, it is advised to perform measurement-based QA. Since
measurement-based methods are typically performed on homogeneous phantom, an independent
dose calculation with heterogeneity correction should also be performed.
To implement the calculation-based method as a QA approach using Eclipse, the independent dose calculation software has to be modeled accurately because the results of independent
IMRT dose calculation are dependent on the leaf transmission, rounded leaf ends, and the
tongue-and-groove effect. It should be noted that dose calculation discrepancy does exist due
to differences between the TPSs treatment of heterogeneities (collapsed cone vs. AAA). The
verification by independent dose calculation shows the difference in dose calculations between
the Pinnacle and Eclipse treatment planning systems is within ± 3% for head-and-neck, prostate,
breast, and rectum cases. For sites in which tissues are nearly homogeneous (prostate), little
heterogeneity error would be expected from independent of the dose calculation algorithm. For
heterogeneous geometries (lung, head-and-neck), the heterogeneity errors would be expected
to be greater. These were also seen in Tables 3 and 4 from our study. Approximations or inaccuracies in the conversion from MLC leaf sequences to fluence or intensity maps to be used
by the dose calculation algorithm in Eclipse and Pinnacle treatment systems could also lead
the dose differences between the two treatment planning systems. Such discrepancies should
be expected and understood, while variance from such discrepancy should be an indicator of
errors. Depending on the limitation and implementation of the algorithms that are used, there
could be large discrepancies in certain situations (e.g., lung tumors with small PTVs) with AAA
and collapsed cone algorithms.(32) Thus this technique has limitations, and in such scenarios
one must apply it with an understanding of the differences in algorithms.
The goal of the study is not to propose the use or purchase of the second commercial
planning system. The goal is to study different QA paradigms in a quest to understand the effectiveness and efficiency. We had several choices for independent dose calculation software.
We consciously decided to use a commercial, extensively tested independent dose calculation
system as the secondary TPS. The reason for this was to choose an equally robust and verified
dose calculator to avoid introducing other uncertainties into the paradigm. We thought the best
choice would be a commissioned FDA-approved TPS which has been routinely used in our
clinic for a several years.
This is a process that is shown to be effective and it is important to have independent dose
calculation software as good as a commercial TPS at a reasonable cost to provide safe and
quality treatments.
V. Conclusions
The present verification procedure with independent dose calculation followed by machine log
file analysis is a reliable tool to verify the IMRT treatment. It allows the assessment of dose
distribution in the patient anatomy, which cannot be obtained with conventional measurements
using ICs or MapCHECK in a homogenous phantom. It can verify not only the calculation
inaccuracies, but also verify the data transfer and evaluate the performance of the MLC delivery. Machine log file analysis is a much more sensitive tool of data transfer/entry discrepancy
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than measurement-based techniques. This method offers significant advantage in reducing the
time needed for the QA and it is less labor-intensive. With the IMRT QA program becoming
more mature, independent dose calculations and machine log analysis may be used to replace
or compliment experimental-based verification methods.
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